27 October 2026
Sidley Represents Bolt Biotherapeutics in the Acquisition of Prana Therapies and Concurrent US$120 Million Private Placement Financing
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Frank Rahmani Lead | Sidley | Not stated | Emerging Companies and Venture Capital, Capital Markets | Not stated |
| Nick DeAngelis Lead | Sidley | Not stated | M&A | Not stated |
| Asher Rubin Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Molly Homann | Sidley | Not stated | M&A | Not stated |
| Becca Davis | Sidley | Not stated | M&A | Not stated |
| Charles Santoro | Sidley | Not stated | M&A | Not stated |
| Karim Pirani | Sidley | Not stated | Employee Benefits and Executive Compensation | Not stated |
| Alison Lehner | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Christian Brause | Sidley | Not stated | Tax | Not stated |
| Torrey Cope | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Julea Lipiz | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Karena Kong | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 120m ($120 million)
- What the figure measures
- Issue size
- Client
- Bolt Biotherapeutics, Inc.Buy-side
- Counterparties
- Prana Therapies, Inc. (Sell-side)